HCA Healthcare, Inc.

HCA Healthcare Medical Care Facilities

HCA Healthcare, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $75.6 billion, up 7.08% from fiscal 2024. In the quarter to June 2026, revenue grew 8.73%, EPS grew 11.6%, free cash flow fell 63.6% and total debt rose 11.8%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for five consecutive years, revenue growth for ten, operating cash flow growth for three.

457.58 10.92 −2.33%
Market cap
$101.4B
P/E
15.3×
Fwd P/E
12.3×
Dividend yield
0.67%
F-score
7/9
Altman Z
2.80
Beneish M
−2.87
Dividend safety
78/100

HCA Healthcare, Inc. (HCA) EV/Sales

Alert me on EV/Sales

As of 16 October 2026, HCA Healthcare, Inc. (HCA) trades at a EV/Sales of 1.9×. Over the past ten years it has ranged from 1.1× (March 2020) to 2.3× (March 2026); the current reading is higher than 86% of that period. That is above the Medical Care Facilities industry median of 1.3× and below the Healthcare sector median of 3.4×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2025 2.1× 22.58%
FY2024 1.7× (3.88%)
FY2023 1.7× (2.25%)
FY2022 1.8× (9.51%)
FY2021 2.0× 20.12%
FY2020 1.6× 1.18%
FY2019 1.6× 0.54%
FY2018 1.6× 9.00%
FY2017 1.5× 3.90%
FY2016 1.4× (1.83%)

Quarterly newest first

Period EV/Sales Change
Jun 2026 1.7× (13.74%)
Mar 2026 2.0× (2.90%)
Dec 2025 2.1× 7.37%
Sep 2025 1.9× 3.24%
42 more quarters

Against its own ten years

Low 1.1× High 2.3×
Ten-year median 1.7×
Current reading's percentile 85

EV/Sales against peers

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on HCA